| Name | CD9 antigen | ||
| UniProt ID | CD9_HUMAN | ||
| Gene Name | CD9 | ||
| Gene ID | 928 | ||
| Synonyms |
CD9, BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29
|
||
| Sequence |
MPVKGGTKCIKYLLFGFNFIFWLAGIAVLAIGLWLRFDSQTKSIFEQETNNNNSSFYTGV
YILIGAGALMMLVGFLGCCGAVQESQCMLGLFFGFLLVIFAIEIAAAIWGYSHKDEVIKE VQEFYKDTYNKLKTKDEPQRETLKAIHYALNCCGLAGGVEQFISDICPKKDVLETFTVKS CPDAIKEVFDNKFHIIGAVGIGIAVVMIFGMIFSMILCCAIRRNREMV |
||
| Pathway Map | MAP LINK | ||
| T.C. Number | 8.A.40.1.9 | ||
| KEGG ID | hsa928 | ||
| TTD ID | T50574 | ||
| Pfam | PF00335; PF03620; PF04103 | ||
| Pair Name | Fucoxanthin, Doxorubicin | |||
| Phytochemical | Fucoxanthin | |||
| Drug | Doxorubicin | |||
| Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
| Regulate Info | Down-regulation | CD9 antigen | Expression | |
| Result | The carotenoid fucoxanthin can sensitize multidrug resistant cancer cells to doxorubicin via induction of apoptosis, inhibition of multidrug resistance proteins and metabolic enzymes | |||
